NCT05395208

Brief Summary

Newborns hospitalized with some respiratory problems in the clinic are taken to noninvasive mechanical ventilation support and vascular access is required for some treatments to be applied to these newborns. The presence of nasal cannulas used for noninvasive mechanical ventilation support in newborns causes restlessness, agitation and stress in infants. The uneasiness and stress experienced by babies during vascular access also affects effective vascular access, causing other doses to be delayed or skipped due to treatment doses that are not completed on time. In addition, the pain experienced by babies indirectly affects nurses. It has been reported in many studies that it is effective in reducing the pain experienced by newborns with non-pharmacological methods. Simultaneous white noise will be played and therapeutic touch applied to help touch methods and white noise listening help reduce or control newborns' pain. Many studies have shown that touching to and listening white noise is effective in reducing pain. This study was planned as a randomized controlled experimental study to determine the effect of white noise-accompanied therapeutic touch application on pain level and physiological parameters and noninvasive mechanical ventilation support during peripheral intravenous catheterization in premature infants hospitalized for treatment. Hypothesis 0: The application of therapeutic touch with white noise during peripheral intravenous catheter intervention in premature infants has no effect on the level of pain. Hypothesis 1: White noise-accompanied therapeutic touch application reduces pain level during peripheral intravenous catheter intervention in premature infants. Hypothesis 2: The therapeutic touch application accompanied by white noise during peripheral intravenous catheter intervention in premature infants positively affects physiological parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2021

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2022

Enrollment Period

7 months

First QC Date

May 12, 2022

Last Update Submit

May 26, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pain Score

    NIPS: Newborn Infant Pain Scale was evaluated. The Newborn Infant Pain Scale consists of 6 behavioral parts: facial expression, crying, breathing pattern, arm and leg movements, and alertness. Apart from crying, 2 separate points (0-1 points) are given for other behaviors, and 3 separate points (0-1-2) are given for crying. The total score varies between 0-7. A high score indicates increased pain intensity. According to the scale scoring: 0 Points: No pain, 1-2 Points: Mild pain, 3-4 Points: Moderate pain, 5-7 Points: Severe pain.

    Before intravenous catheter intervention (5 minutes ago)

  • Pain Score

    NIPS: Newborn Infant Pain Scale was evaluated. The Newborn Infant Pain Scale consists of 6 behavioral parts: facial expression, crying, breathing pattern, arm and leg movements, and alertness. Apart from crying, 2 separate points (0-1 points) are given for other behaviors, and 3 separate points (0-1-2) are given for crying. The total score varies between 0-7. A high score indicates increased pain intensity. According to the scale scoring: 0 Points: No pain, 1-2 Points: Mild pain, 3-4 Points: Moderate pain, 5-7 Points: Severe pain.

    Intravenous catheter attempt sequence (0th. minute)

  • Pain Score

    NIPS: Newborn Infant Pain Scale was evaluated. The Newborn Infant Pain Scale consists of 6 behavioral parts: facial expression, crying, breathing pattern, arm and leg movements, and alertness. Apart from crying, 2 separate points (0-1 points) are given for other behaviors, and 3 separate points (0-1-2) are given for crying. The total score varies between 0-7. A high score indicates increased pain intensity. According to the scale scoring: 0 Points: No pain, 1-2 Points: Mild pain, 3-4 Points: Moderate pain, 5-7 Points: Severe pain.

    Immediately after intravenous catheter intervention (0th minute)

  • Pain Score

    NIPS: Newborn Infant Pain Scale was evaluated. The Newborn Infant Pain Scale consists of 6 behavioral parts: facial expression, crying, breathing pattern, arm and leg movements, and alertness. Apart from crying, 2 separate points (0-1 points) are given for other behaviors, and 3 separate points (0-1-2) are given for crying. The total score varies between 0-7. A high score indicates increased pain intensity. According to the scale scoring: 0 Points: No pain, 1-2 Points: Mild pain, 3-4 Points: Moderate pain, 5-7 Points: Severe pain.

    5 minutes after intravenous catheterization

Secondary Outcomes (19)

  • Blood pressure Vital Signs

    Before intravenous catheter intervention (5 minutes ago)

  • Blood pressure Vital Signs

    Immediately after intravenous catheter intervention (0th minute)

  • Blood pressure Vital Signs

    5 minutes after intravenous catheterization

  • Oxygen saturation Vital Signs

    Before intravenous catheter intervention (5 minutes ago)

  • Oxygen saturation Vital Signs

    Intravenous catheter attempt sequence (0th. minute)

  • +14 more secondary outcomes

Study Arms (2)

Therapeutic touch group accompanied by white noise

EXPERIMENTAL

* Camera recording was started 5 minutes before intravenous catheter intervention, vital signs and pain were evaluated. * Therapeutic touch application with white noise was started. * Vital signs and pain were evaluated during intravenous catheterization. * Vital signs and pain were evaluated when the intravenous catheter intervention was terminated and 5 minutes later, and the camera recording was stopped.

Behavioral: Therapeutic touch group accompanied by white noise

Control group

NO INTERVENTION

* Camera recording was started 5 minutes before the intravenous catheter intervention, vital signs and pain were evaluated. * No application was made other than intravascular catheter intervention. * Vital signs and pain were evaluated during intravenous catheterization. * Vital signs and pain were evaluated when the intravenous catheter intervention was terminated and 5 minutes later, and the camera recording was stopped.

Interventions

During the intravenous catheter intervention, approximately 15-20 minutes of white noise was applied with therapeutic touch.

Therapeutic touch group accompanied by white noise

Eligibility Criteria

Age32 Weeks - 36 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • To be in noninvasive mechanical ventilation support,
  • Newborns between 32-36 weeks,
  • Not having a life-threatening disease,
  • No congenital anomalies,
  • Appropriate cognitive level and motor development of the newborn,
  • The newborn does not have a physical problem,
  • Parents' willingness to participate in the research,

You may not qualify if:

  • Presence of IV catheter,
  • Having a condition that prevents vascular access,
  • Those who have circulation problems in the body,
  • Using narcotic, sedative opioid and anticonvulsant drugs
  • Pharmacological intervention application for the baby's pain during the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Home/Work

Istanbul, Üsküdar, 34674, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gülzade Uysal, Assoc. Dr.

    Okan Üniversitesi

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Randomized Controlled two groups (control groups and intervention group)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
NURSE

Study Record Dates

First Submitted

May 12, 2022

First Posted

May 27, 2022

Study Start

June 1, 2021

Primary Completion

December 15, 2021

Study Completion

January 12, 2022

Last Updated

May 27, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations